EECP treatment (Enhanced External Counterpulsation)

EECP stands for Enhanced External Counterpulsation. It is a non-invasive, outpatient treatment in which inflatable cuffs wrapped around the legs squeeze and release in time with your heartbeat. It is used mainly to reduce symptoms of chronic stable angina in people whose chest pain continues despite medicines and who are not suitable for — or do not wish to have — angioplasty or bypass surgery.

EECP does not remove or dissolve blockages in the coronary arteries. Its aim is to reduce angina episodes and improve exercise tolerance and quality of life for some patients.

You lie on a padded treatment table. Three pairs of cuffs are wrapped around your calves, lower thighs and upper thighs. An ECG monitors your heart rhythm so the machine can time each cycle precisely:

• When the heart relaxes (diastole), the cuffs inflate in sequence from calves upward, pushing blood back towards the heart and increasing blood pressure in the aorta — which can increase blood flow into the coronary arteries.

• Just before the heart contracts (systole), the cuffs deflate together, lowering the resistance the heart pumps against.

Sessions are painless for most people, though the squeezing feels firm. You can usually read, listen to music or rest during treatment.

• Chronic stable angina that persists despite optimal medical therapy (refractory angina) — the main evidence-supported use.

• Selected patients with coronary artery disease who are not candidates for further revascularisation.

• It has been studied in stable heart failure, but evidence is limited and it is not a standard heart-failure treatment.

EECP may be considered for adults who:

• have angina that limits daily activities despite medicines prescribed by a cardiologist;

• have been assessed and found not suitable for angioplasty or bypass, or have high surgical risk;

• prefer a non-invasive option after discussing the evidence and alternatives with their cardiologist.

Suitability is decided only after a full clinical evaluation.

EECP is generally not recommended, or needs special caution, if you have:

• an irregular heart rhythm that prevents accurate timing (for example, poorly controlled atrial fibrillation or very frequent ectopic beats);

• decompensated (unstable) heart failure;

• moderate to severe aortic valve regurgitation;

• significant peripheral arterial disease of the legs, deep vein thrombosis or active phlebitis;

• an aortic aneurysm needing repair;

• very high uncontrolled blood pressure;

• a bleeding tendency or blood-thinner levels outside the safe range advised by your doctor;

• recent cardiac catheterisation with a groin puncture that has not fully healed;

• pregnancy.

Before EECP, a cardiologist reviews your history, medicines and previous reports. Assessment usually includes a clinical examination, blood pressure, ECG and often echocardiography, and a check of leg circulation. If you have not had a recent evaluation for blocked arteries, your doctor may recommend tests first so that procedures such as angioplasty are not missed when they are the better option.

A standard course studied in trials is 35 one-hour sessions, usually five days a week for about seven weeks. Your vital signs and symptoms are monitored throughout. You continue your usual heart medicines unless your doctor advises otherwise.

In the randomised MUST-EECP trial, people with stable angina who received active EECP had fewer angina episodes and a longer time to ECG signs of ischaemia during exercise than a sham group. Registry data report symptom improvement in many patients, sometimes lasting for months to years, but registry data cannot prove cause and effect.

European (ESC) and American (ACC/AHA) guidelines list EECP as a treatment that may be considered for refractory angina — a weaker recommendation that reflects limited evidence. EECP has not been shown to reduce heart attacks or deaths.

• Leg discomfort, skin redness or abrasions under the cuffs.

• Tiredness or muscle aches after early sessions.

• Rarely, worsening heart failure symptoms in people with poor heart function — which is why careful selection and monitoring matter.

Limitations: EECP does not clear blockages, does not replace angioplasty or bypass when these are indicated (for example, in a heart attack or certain high-risk blockages), and not everyone improves.

There is no recovery period; most people return to normal activities straight after each session. Your cardiologist will review symptoms at the end of the course and plan ongoing risk-factor control, medicines and, where appropriate, cardiac rehabilitation.

• Optimising anti-anginal and preventive medicines.

• Percutaneous coronary intervention (angioplasty and stenting).

• Coronary artery bypass grafting (CABG).

• Structured cardiac rehabilitation and lifestyle change.

• Specialist referral for other refractory-angina therapies where available.

Read our guide comparing EECP, angioplasty and bypass.

Cost depends on the number of sessions, tests needed beforehand and your insurance coverage. We provide a written estimate after your assessment. Ask your insurer whether EECP is covered under your policy.